Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CSBR > SEC Filings for CSBR > Form 8-K on 17-Oct-2013All Recent SEC Filings

Show all filings for CHAMPIONS ONCOLOGY, INC.

Form 8-K for CHAMPIONS ONCOLOGY, INC.


17-Oct-2013

Submission of Matters to a Vote of Security Holders


Item 5.07. Submission of Matters to a Vote of Security Holders.

On October 15, 2013, Champion's Oncology, Inc. (the "Company") held its Annual Meeting of the Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows, there being no broker non-votes for any matter:

1. Election of Directors. The seven director nominees named in the Company's 2013 proxy statement were elected to serve for a one-year term expiring at the 2014 Annual Meeting of the Stockholders or until their successors are duly elected and qualified, based upon the following votes:

                  Director Nominee     Votes For  Votes Withheld
                  Joel Ackerman        42,005,674     2,000
                  Arthur G. Epker III  42,004,574     3,100
                  Daniel Mendelson     42,005,474     2,100
                  Ronnie Morris, M.D.  42,005,674     2,000
                  Abba David Poliakoff 42,004,574     3,100
                  David Sidransky      42,005,474     2,100
                  Scott R. Tobin       42,005,474     2,100

2. Ratification of Appointment of Independent Registered Accounting Firm. The appointment of Ernst & Young LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2014, was ratified as follows:

Votes For Votes Against Abstain 41,983,598 3,550 46

3. Advisory Vote of the Compensation of the Company's Named Executive Officers. The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Company's 2013 proxy statement, was approved by the following votes:

Votes For Votes Against Abstain 41,942,786 3,196 41,212

4. Advisory Vote on the Frequency of the Advisory Vote on the Compensation of our Named Executive Officers. The Company's stockholders recommended, on an advisory basis, to hold an advisory vote on the compensation of the Company's named executive officers on an annual basis, by the votes set forth in the table below:

One-Year Two-Year Three-Year Frequency Vote Frequency Vote Frequency Vote Abstain 29,273,235 17,044 12,696,603 312

5. Reverse Split. The proposal to grant the Company's Board of Directors the discretionary authority to consummate a reverse split of the Company's common stock was approved by the following votes:

Votes For Votes Against Abstain 41,952,932 33,162 1,100

  Add CSBR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CSBR - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.